West Pharmaceutical Services Inc. (NYSE:WST) CFO William J. Federici sold 54,996 shares of the firm’s stock in a transaction that occurred on Thursday, May 18th. The shares were sold at an average price of $95.45, for a total value of $5,249,368.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

West Pharmaceutical Services Inc. (NYSE:WST) traded down 0.99% during mid-day trading on Thursday, reaching $95.08. The company’s stock had a trading volume of 378,992 shares. The company has a 50 day moving average of $86.85 and a 200-day moving average of $83.72. West Pharmaceutical Services Inc. has a 52-week low of $70.17 and a 52-week high of $96.97. The stock has a market cap of $6.99 billion, a PE ratio of 39.35 and a beta of 0.94.

West Pharmaceutical Services (NYSE:WST) last announced its earnings results on Thursday, April 27th. The medical instruments supplier reported $0.81 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.55 by $0.26. The company had revenue of $387.70 million for the quarter, compared to analyst estimates of $380.42 million. West Pharmaceutical Services had a return on equity of 14.54% and a net margin of 9.27%. The firm’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter last year, the company earned $0.53 earnings per share. Equities analysts forecast that West Pharmaceutical Services Inc. will post $2.73 earnings per share for the current year.

Insider Buying and Selling by Quarter for West Pharmaceutical Services (NYSE:WST)

The company also recently announced a quarterly dividend, which will be paid on Wednesday, August 2nd. Stockholders of record on Wednesday, July 19th will be paid a dividend of $0.13 per share. The ex-dividend date of this dividend is Monday, July 17th. This represents a $0.52 dividend on an annualized basis and a dividend yield of 0.55%. West Pharmaceutical Services’s dividend payout ratio (DPR) is currently 28.11%.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another website, it was copied illegally and reposted in violation of US and international trademark and copyright legislation. The original version of this piece of content can be read at https://www.americanbankingnews.com/2017/05/18/william-j-federici-sells-54996-shares-of-west-pharmaceutical-services-inc-wst-stock.html.

WST has been the topic of a number of recent analyst reports. Zacks Investment Research downgraded West Pharmaceutical Services from a “hold” rating to a “sell” rating in a research note on Friday, February 24th. Jefferies Group LLC raised their price objective on West Pharmaceutical Services from $76.00 to $82.00 and gave the company a “hold” rating in a research note on Tuesday, January 24th.

Several institutional investors have recently made changes to their positions in the company. Burt Wealth Advisors raised its position in shares of West Pharmaceutical Services by 38,540.0% in the first quarter. Burt Wealth Advisors now owns 1,932 shares of the medical instruments supplier’s stock worth $158,000 after buying an additional 1,927 shares during the period. Asset Management One Co. Ltd. purchased a new position in shares of West Pharmaceutical Services during the fourth quarter worth $164,000. Tyers Asset Management LLC purchased a new position in shares of West Pharmaceutical Services during the fourth quarter worth $178,000. Harfst & Associates Inc. purchased a new position in shares of West Pharmaceutical Services during the first quarter worth $186,000. Finally, Cambridge Investment Research Advisors Inc. raised its position in shares of West Pharmaceutical Services by 1.6% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 2,569 shares of the medical instruments supplier’s stock worth $210,000 after buying an additional 40 shares during the period. Institutional investors own 90.31% of the company’s stock.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

5 Day Chart for NYSE:WST

Receive News & Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related companies with MarketBeat.com's FREE daily email newsletter.